N-[4-(4-morpholinyl)butyl]-2-benzofurancarboxamide has been researched along with Cirrhosis in 1 studies
CL82198: a selective inhibitor of MMP13
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ren, J | 1 |
| Zhang, J | 1 |
| Rudemiller, NP | 1 |
| Griffiths, R | 1 |
| Wen, Y | 1 |
| Lu, X | 1 |
| Privratsky, JR | 1 |
| Gunn, MD | 1 |
| Crowley, SD | 1 |
1 other study available for N-[4-(4-morpholinyl)butyl]-2-benzofurancarboxamide and Cirrhosis
| Article | Year |
|---|---|
Twist1 in Infiltrating Macrophages Attenuates Kidney Fibrosis
Topics: Actins; Animals; Benzofurans; Collagen Type I; CX3C Chemokine Receptor 1; Disease Models, Animal; Ex | 2019 |